Skip to main content

Table 1 Type of tumor, WHO grading and gender of brain tumors patients

From: Serum and cerebrospinal fluid Neudesin concentration and Neudesin Quotient as potential circulating biomarkers of a primary brain tumor

Type of tumor (WHO grading)

Gender

Patients with astrocytic brain tumor

(11 M/9F; mean age 57 ± years, range 39–73 years)

 Diffuse astrocytoma (2)

M

 Glioblastoma (4)

M

 Anaplastic astrocytoma (4)

M

 Glioblastoma (4)

M

 Gliosarcoma (4)

M

 Glioblastoma (4)

M

 Anaplastic glioma (3)

M

 Glioblastoma (4)

M

 Pilocytic astrocytoma (1)

M

 Glioblastoma (4)

M

 Glioblastoma (4)

M

 Glioblastoma (4)

F

 Diffuse astrocytoma (2)

F

 Glioblastoma (4)

F

 Glioblastoma (4)

F

 Glioblastoma (4)

F

 Glioblastoma (4)

F

 Glioma (4)

F

 Glioblastoma (4)

F

 Anaplastic astrocytoma (3)

F

Patients with tumor of the meninges

(1 M/7F; mean age 54 ± years, range 36–68 years)

 Anaplastic meningioma (3)

M

 Transitional meningioma with psammoma bodies (1)

F

 Psammomatous meningioma (1)

F

 Transitional meningioma (1)

F

 Meningothelial meningioma (1)

F

 Fibroblastic meningioma (1)

F

 Psammomatous meningioma (1)

F

 Meningothelial meningioma (1)

F

  1. WHO World Health Organization, M male, F female